General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0ERFMZ
ADC Name
CN118001423A ADC2
Synonyms
ADC2
   Click to Show/Hide
Organization
HANGZHOU ADCORIS BIOPHARMA CO LTD
Drug Status
Investigative
Drug-to-Antibody Ratio
8
Structure
Antibody Name
undisclosed
Antigen Name
Nectin-4 (NECTIN4)
 Antigen Info 
Payload Name
CN118001423A+ADC2+payload
 Payload Info 
Linker Name
CN118001423A+ADC1+Linker
 Linker Info 
Conjugate Type
DBCO-Azide Click Chemistry Conjugation
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Click To Hide/Show 5 Activity Data Related to This Level
Standard Type Value Units Cell Line Disease Model
Half Maximal inhibitory Concentration (lC50) 
< 50
nM
CVCL_0419
Breast adenocarcinoma
Half Maximal inhibitory Concentration (lC50) 
≈ 50&#8776;200
nM
CVCL_1728
Mouse melanoma
Half Maximal inhibitory Concentration (lC50) 
≈ 50&#8776;200
nM
CVCL_0031
Invasive breast carcinoma
Half Maximal inhibitory Concentration (lC50) 
< 50
nM
CVCL_0395
Prostate carcinoma
Half Maximal inhibitory Concentration (lC50) 
< 50
nM
CVCL_0186
Pancreatic ductal adenocarcinoma
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Click To Hide/Show 5 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) < 50 nM High NECTIN4 expression (NECTIN4 +++)
Method Description
A Cell line test on MDA-MB-468
In Vitro Model Breast adenocarcinoma MDA-MB-468 cells CVCL_0419
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) ≈ 50≈200 nM High NECTIN4 expression (NECTIN4 +++)
Method Description
A Cell line test on SW-780
In Vitro Model Mouse melanoma SW-780 cells CVCL_1728
Experiment 3 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) ≈ 50≈200 nM High NECTIN4 expression (NECTIN4 +++)
Method Description
A Cell line test on MCF-7
In Vitro Model Invasive breast carcinoma MCF-7 cells CVCL_0031
Experiment 4 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) < 50 nM High NECTIN4 expression (NECTIN4 +++)
Method Description
A Cell line test on LNCAP
In Vitro Model Prostate carcinoma LNCaP cells CVCL_0395
Experiment 5 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) < 50 nM High NECTIN4 expression (NECTIN4 +++)
Method Description
A Cell line test on BxPC-3
In Vitro Model Pancreatic ductal adenocarcinoma BxPC-3 cells CVCL_0186
References
Ref 1 Hydrophilic anti-Nectin-4 antibody-drug conjugates and their preparation methods and uses